| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
||
From the Department of Pathology and the Center for Neurobiology and Behavior,* Columbia University, New York, New York; and the University of North Carolina Neuroscience Center, Curriculum in Neurobiology, Department of Biochemistry and Biophysics, Department of Pathology and Laboratory Medicine, Program in Molecular Biology and Biotechnology and Department of Microbiology and Immunology,|| University of North Carolina, Chapel Hill, North Carolina
To understand mechanisms that may underlie the progression of a demyelinated lesion to a chronic state, we have used the cuprizone model of chronic demyelination. In this study, we investigated the fate of oligodendrocytes during the progression of a demyelinating lesion to a chronic state and determined whether transplanted adult oligodendrocyte progenitors could remyelinate the chronically demyelinated axons. Although there is rapid regeneration of the oligodendrocyte population following an acute lesion, most of these newly regenerated cells undergo apoptosis if mice remain on a cuprizone diet. Furthermore, the oligodendrocyte progenitors also become progressively depleted within the lesion, which appears to contribute to the chronic demyelination. Interestingly, even if the mice are returned to a normal diet following 12 weeks of exposure to cuprizone, remyelination and oligodendrocyte regeneration does not occur. However, if adult O4+ progenitors are transplanted into the chronically demyelinated lesion of mice treated with cuprizone for 12 weeks, mature oligodendrocyte regeneration and remyelination occurs after the mice are returned to a normal diet. Thus, the formation of chronically demyelinated lesions induced by cuprizone appears to be the result of oligodendrocyte depletion within the lesion and not due to the inability of the chronically demyelinated axons to be remyelinated.
This article has been cited by other articles:
 |
|
 |
|
  O. Einstein, Y. Friedman-Levi, N. Grigoriadis, and T. Ben-Hur Transplanted Neural Precursors Enhance Host Brain-Derived Myelin Regeneration J. Neurosci., December 16, 2009; 29(50): 15694 - 15702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mela and J. E. Goldman The Tetraspanin KAI1/CD82 Is Expressed by Late-Lineage Oligodendrocyte Precursors and May Function to Restrict Precursor Migration and Promote Oligodendrocyte Differentiation and Myelination J. Neurosci., September 9, 2009; 29(36): 11172 - 11181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-A. Harsan, J. Steibel, A. Zaremba, A. Agin, R. Sapin, P. Poulet, B. Guignard, N. Parizel, D. Grucker, N. Boehm, et al. Recovery from Chronic Demyelination by Thyroid Hormone Therapy: Myelinogenesis Induction and Assessment by Diffusion Tensor Magnetic Resonance Imaging J. Neurosci., December 24, 2008; 28(52): 14189 - 14201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kuhlmann, V. Miron, Q. Cuo, C. Wegner, J. Antel, and W. Bruck Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis Brain, July 1, 2008; 131(7): 1749 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Chandran, D. Hunt, A. Joannides, C. Zhao, A. Compston, and R. J.M Franklin Myelin repair: the role of stem and precursor cells in multiple sclerosis Phil Trans R Soc B, January 12, 2008; 363(1489): 171 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nishiyama Polydendrocytes: NG2 Cells with Many Roles in Development and Repair of the CNS Neuroscientist, February 1, 2007; 13(1): 62 - 76. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Mana, D. Linares, S. Fordham, M. Staykova, and D. Willenborg Deleterious Role of IFN{gamma} in a Toxic Model of Central Nervous System Demyelination Am. J. Pathol., May 1, 2006; 168(5): 1464 - 1473. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
